Australia markets closed

Immunic, Inc. (IMUX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.1100+0.0900 (+8.82%)
At close: 04:00PM EDT
1.1208 +0.01 (+0.97%)
After hours: 06:24PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
78,988
83,215
71,255
61,115
38,637
Selling general and administrative
16,865
16,008
15,263
13,300
10,334
Total operating expenses
95,853
99,223
86,518
91,665
48,971
Operating income or loss
-95,853
-99,223
-86,518
-91,665
-48,971
Total other income/expenses net
-5,533
2,536
-34,930
-1,346
4,896
Income before tax
-97,924
-93,612
-120,407
-92,945
-44,017
Income from continuing operations
-97,924
-93,612
-120,407
-92,945
-44,017
Net income
-97,924
-93,612
-120,407
-92,945
-44,017
Net income available to common shareholders
-97,924
-93,612
-120,407
-92,945
-44,017
Basic EPS
-3.25
-2.11
-3.78
-3.93
-2.81
Diluted EPS
-3.25
-2.11
-3.78
-3.93
-2.81
Basic average shares
42,747
44,320
31,819
23,653
15,664
Diluted average shares
42,747
44,320
31,819
23,653
15,664